COST OF TREATMENT HYPERTENTION INPATIENTS IN VIETNAM

Author(s)

Nguyen TT1, Nguyen TV2, Vu TT2, Nguyen HN3
1University of medicine and pharmacy, Ho Chi Minh City, Ho Chi Minh City, Viet Nam, 2University of Medicine and Pharmacy, Ho Chi Minh City, Ho CHi Minh, Viet Nam, 3General Hospital of Tran Van Thoi Region, Ho CHi Minh, Viet Nam

OBJECTIVES: Hypertention is a common non-communicable diseases in both male and female populations, 1 out of every 3 adults have high blood pressure. Reseaches in treatment cost of hypertension in Vietnam were limited. Therefore, the aim of this study was evaluate the treatment cost of patients with hypertension. METHODS: A cross-sectional study was conducted with database of all patients hospitalized for hypertension at Tran Van Thoi hospital within 2014 and 2015. Patients who did not finish the treatment course in research hospital or died within treatment were eliminated from this study. The medical direct cost was evaluated in this study. RESULTS: Data from 1939 patients with nearly 70% female, 72.1% over 60 years old; in 85.7% with health insurance, 26% patiens with cardiovascular diseases and 72% having other disease except hypertension was analysed. With average hospital stay length of 6 days, the average total cost per patient was 755.48±12.55 thousand VND, including 76% covered by health insurance and 24% covered by patients. In the stucture of total cost, cost for preclinical tests, medications and hospital beds were 312,8±2,1; 202,6 ± 9,2 and 148,1±1,9 thousand VND, respectively. The influencing factors on the total treatment cost include gender (p=0.001); occupation (p=0.008). The total treatment cost of male was higher than those of female (827.7 and 723.7 thousand VND, p=0.001). There was a statistical significant difference between total treatment cost of farmers and retired patients (680.8; 782.2 thousand VND and p = 0.009). CONCLUSIONS: The total treatment cost was 755.48±12.55 thousand VND with majority part for preclinical test. The main factors affecting the total cost of hypertention inpatients include gender, occupation.

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCV76

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×